Volume 65, Issue 6, Pages (June 2004)

Slides:

Advertisements

Similar presentations

Chapter 1: Definition and classification of CKD Kidney International Supplements Volume 3, Issue 1, Pages (January 2013) DOI: /kisup

Advertisements

Management of IgA nephropathy: Evidence-based recommendations

Melamine toxicity: one more culprit in calcium kidney lithiasis

Beta blockers in the management of chronic kidney disease

Plasma sodium and hypertension

Francesco Locatelli, Lucia Del Vecchio, Simeone Andrulli, Sara Colzani

Prehypertension and chronic kidney disease: the ox or the plow?

Reassessment of the care of the patient with chronic kidney disease

Volume 80, Issue 10, Pages (November 2011)

Progression of renal failure and hypertensive nephrosclerosis

Volume 90, Issue 3, Pages (September 2016)

Homocysteine and risk in end-stage renal disease: a matter of context

Progression of diabetic nephropathy

Volume 54, Issue 4, Pages (October 1998)

Comorbidity and confounding in end-stage renal disease

Volume 74, Issue 3, Pages (August 2008)

A new era in phosphate binder therapy: What are the options?

The importance of increased dialysis and anemia management for infant survival in pregnant women on hemodialysis Sai Subhodhini Reddy, Jean L. Holley

Volume 74, Issue 3, Pages (August 2008)

Volume 70, Issue 11, Pages (December 2006)

Renal risk scores: Progress and prospects

Volume 71, Issue 11, Pages (June 2007)

Volume 87, Issue 2, Pages (February 2015)

Achieving blood pressure targets during dialysis improves control but increases intradialytic hypotension A. Davenport, C. Cox, R. Thuraisingham Kidney.

Volume 71, Issue 11, Pages (June 2007)

U-shaped effect of eGFR and mortality

Volume 71, Issue 6, Pages (March 2007)

Melamine toxicity: one more culprit in calcium kidney lithiasis

Blood pressure targets in hemodialysis patients

Volume 70, Issue 7, Pages (October 2006)

Volume 76, Issue 5, Pages (September 2009)

Capturing the in vivo molecular signature of the podocyte

The third World Kidney Day: Looking back and thinking forward

Volume 61, Issue 6, Pages (June 2002)

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Alternate-day dialysis may be needed for hemodialysis patients

Nephrology Crossword: Peritoneal Dialysis

Environmental exposure to lead and progressive diabetic nephropathy in patients with type II diabetes J.-L. Lin, D.-T. Lin-Tan, C.-C. Yu, Y.-J. Li, Y.-Y.

The kidney, a cardiovascular risk marker, and a new target for therapy

Volume 56, Issue 4, Pages (October 1999)

Counteracting progression of renal disease: A look into the future

Nephrology Crossword: Glomerulonephritis

Volume 80, Issue 3, Pages (August 2011)

Renal and vascular function in women with previous preeclampsia: A comparison of low- and high-degree proteinuria K.H. Lampinen, M. Rönnback, P.-H. Groop,

Circadian regulation of renal function

Prehypertension: is it relevant for nephrologists?

Proteinuria screening for children

Volume 67, Pages S15-S19 (January 2005)

The course of the remnant kidney model in mice

Organ transplantation goes to the movies

Atherosclerotic nephropathy

Volume 55, Pages S3-S16 (June 1999)

Volume 80, Issue 10, Pages (November 2011)

Volume 75, Issue 12, Pages (June 2009)

Volume 72, Issue 7, Pages (October 2007)

Is it the low-protein diet or simply the salt restriction?

Volume 64, Issue 4, Pages (October 2003)

Charles A. Herzog Kidney International

Volume 70, Issue 3, Pages (August 2006)

Importance of blood pressure control in hemodialysis patient survival

Volume 70, Issue 5, Pages (September 2006)

Tobias Breidthardt, Alexandre Mebazaa, Christian E. Mueller

Volume 56, Issue 4, Pages (October 1999)

Membranous nephropathy: recent travels and new roads ahead

The international realities of live donor kidney transplantation

Volume 70, Issue 10, Pages (November 2006)

The International Pediatric Peritonitis Registry: Starting to walk

Volume 80, Issue 9, Pages (November 2011)

Antonio Piccoli, Luana Pillon Kidney International

Presentation transcript:

Volume 65, Issue 6, Pages 1991-2002 (June 2004) Differential effects of calcium antagonist subclasses on markers of nephropathy progression George L. Bakris, Matthew R. Weir, Michelle Secic, Brett Campbell, Annette Weis-McNulty Kidney International Volume 65, Issue 6, Pages 1991-2002 (June 2004) DOI: 10.1111/j.1523-1755.2004.00620.x Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 1 The change in proteinuria and systolic blood pressure. The percentage change in proteinuria, after adjustment for sample size and study length, for dihydropyridine calcium antagonists (DCAs) and nondihydropyridine calcium antagonists (NDCAs) was 2% and -30%, respectively (P < 0.01). The percentage change in systolic blood pressure, after adjustment for sample size and study length, for DCAs and NDCAs was -13% and -18.5%, respectively (P = 0.28). Kidney International 2004 65, 1991-2002DOI: (10.1111/j.1523-1755.2004.00620.x) Copyright © 2004 International Society of Nephrology Terms and Conditions